DKK3 and cancer: Given its reported oncogenic roles in other cancers.[17, 18, 19] and our observation of stage‐ and compartment‐specific DKK3 expression during PDAC progression (Figure 4A–E), we hypothesized a context‐dependent switch whereby DKK3 is tumor‐suppressive initially but becomes oncogenic at later stages.